Apriori Bio
Cambridge, United States · $51.1M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- aprioribio.com
- Total Funding
- $51.1M
- Last Round
- $1.1M GrantJul 2024
- Rounds
- 2
About
AI-enabled vaccine design company developing variant-proof protection against viral threats, backed by Flagship Pioneering.
Summary
Apriori Bio is an Artificial Intelligence company based in Cambridge, United States. It has raised $51.1M in total across 2 rounds, most recently a $1.1M Grant round in Jul 2024. Investors include Coalition for Epidemic Preparedness Innovations (CEPI) and Flagship Pioneering.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...